======= CRBN =======
== Gene Information ==
* **Official Symbol**: CRBN
* **Official Name**: cereblon
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51185|51185]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96SW2|Q96SW2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CRBN&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CRBN|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609262|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein related to the Lon protease protein family. In rodents and other mammals this gene product is found in the cytoplasm localized with a calcium channel membrane protein, and is thought to play a role in brain development. Mutations in this gene are associated with autosomal recessive nonsyndromic cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010].
* **UniProt Summary**: Substrate recognition component of a DCX (DDB1-CUL4-X- box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. May play a role in memory and learning by regulating the assembly and neuronal surface expression of large-conductance calcium-activated potassium channels in brain regions involved in memory and learning via its interaction with KCNT1. Binding of pomalidomide and other thalidomide-related drugs changes the substrate specificity of the human protein, leading to decreased degradation of MEIS2 and other target proteins and increased degradation of MYC, IRF4, IKZF1 and IKZF3. {ECO:0000269|PubMed:18414909, ECO:0000269|PubMed:20223979, ECO:0000269|PubMed:24328678, ECO:0000269|PubMed:25043012, ECO:0000269|PubMed:25108355, ECO:0000305}.
|LON|
|negative regulation of protein homooligomerization|
|positive regulation of protein homodimerization activity|
|Cul4A-RING E3 ubiquitin ligase complex|
|negative regulation of protein oligomerization|
|regulation of protein homooligomerization|
|regulation of protein homodimerization activity|
|regulation of protein oligomerization|
|positive regulation of protein binding|
|negative regulation of ion transmembrane transport|
|negative regulation of transmembrane transport|
|negative regulation of protein complex assembly|
|negative regulation of ion transport|
|positive regulation of binding|
|regulation of protein binding|
|proteasome-mediated ubiquitin-dependent protein catabolic process|
|proteasomal protein catabolic process|
|regulation of binding|
|regulation of protein complex assembly|
|regulation of ion transmembrane transport|
|negative regulation of transport|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|regulation of transmembrane transport|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|protein catabolic process|
|protein ubiquitination|
|regulation of ion transport|
|negative regulation of cellular component organization|
|protein modification by small protein conjugation|
|nucleolus|
|cellular macromolecule catabolic process|
|regulation of cellular component biogenesis|
|protein modification by small protein conjugation or removal|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|proteolysis|
|organic substance catabolic process|
|positive regulation of molecular function|
|cellular catabolic process|
|regulation of transport|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-2.31|
|[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-2.11|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.12|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|3.05|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10958
* **Expression level (log2 read counts)**: 5.34
{{:chemogenomics:nalm6 dist.png?nolink |}}